NuGen Medical Devices Inc Cash Flow-to-Debt Ratio
NuGen Medical Devices Inc cash flow-to-debt ratio. NuGen Medical Devices Inc (NGMD) has a Cash Flow-to-Debt Ratio of -0.05x as of March 2026, meaning its operating cash flow of CA$-1.01 Million could theoretically repay 0% of its total liabilities (CA$18.51 Million) in one year. Check NGMD cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of NuGen Medical Devices Inc (2020–2025)
Cash flow-to-debt ratio of NuGen Medical Devices Inc from 2020 to 2025. Historical debt coverage capacity for NuGen Medical Devices Inc across 6 annual periods. Also explore NuGen Medical Devices Inc (NGMD) net asset momentum to track the company's year-over-year net asset growth rate.
NuGen Medical Devices Inc Cash Flow-to-Debt Ratio by Year (2020–2025)
NuGen Medical Devices Inc cash flow-to-debt ratio by year from 2020 to 2025. Year-by-year debt coverage analysis for NuGen Medical Devices Inc. For the full cash flow conversion analysis, see NGMD cash flow conversion.
| Year | CF-to-Debt Ratio | Operating CF (CAD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.20x | CA$-3.57 Million | CA$18.03 Million | ▲ +22.1% |
| 2024 | -0.25x | CA$-4.71 Million | CA$18.57 Million | ▲ +65.9% |
| 2023 | -0.75x | CA$-6.71 Million | CA$9.01 Million | ▼ -39.1% |
| 2022 | -0.54x | CA$-4.88 Million | CA$9.11 Million | ▲ +6.0% |
| 2021 | -0.57x | CA$-4.10 Million | CA$7.19 Million | ▼ -523.7% |
| 2020 | -0.09x | CA$-1.39 Million | CA$15.25 Million | — |